A systematic review and meta-analysis of immune checkpoint therapy in relapsed or refractory non-Hodgkin lymphoma; a friend or foe?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A systematic review and meta-analysis of immune checkpoint therapy in relapsed or refractory non-Hodgkin lymphoma; a friend or foe?

Published:2023-04 Issue: Volume:30 Page:101636
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Davoodi-Moghaddam Zeinab,Jafari-Raddani Farideh,Noori Maryam,Bashash Davood^ORCID

Funder

Shahid Beheshti University of Medical Sciences

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference80 articles.

1. Non-Hodgkin lymphoma therapy landscape;Chaudhari;Nat. Rev. Drug Discov.,2019

2. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood;Crump;J. Am. Soc. Hematol.,2017

3. Immune checkpoint inhibitor toxicity;Palmieri;Curr. Oncol. Rep.,2018

4. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

5. The application of nano-medicine to overcome the challenges related to immune checkpoint blockades in cancer immunotherapy: recent advances and opportunities;Sanaei;Crit. Rev. Oncol. Hematol.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel NET-related gene signature for predicting DLBCL prognosis;Journal of Translational Medicine;2023-09-16

2. Vinorelbine and Intermittent Cyclophosphamide Sensitize an Aggressive Myc-Driven B-Cell Lymphoma to Anti-PD-1 by an Immunological Memory Effective against Tumor Re-Challenge;Journal of Clinical Medicine;2023-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP